Zhongxin fluoromaterials: it is planned to acquire 51% equity of Jiangxi Exxon through equity transfer and cash capital increase
Zhongxin fluoro materials announced that it plans to acquire 51% of the equity of Jiangxi Exxon chemical materials Co., Ltd. with RMB 357million through equity transfer and cash capital increase. The existing business of the subject company belongs to the fluorine-containing refrigerant industry.
This text is a result of machine translation.
Related companies：
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
Briefing May 18, 2022 11:24 AM
· Technology
Lithium battery stocks continued to strengthen, and Edison raised the sealing plate
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Mar 10, 2022 09:38 AM
· Technology
Lithium battery stocks rose sharply at the opening, and Meilian new material 20cm trading limit
Technology
Tec-Do 2.0’s Domestic IPO Halted, Shifts to Hong Kong Stock Exchange, sources say
As MarTech Company Tec-Do 2.0 encounters obstacles in its domestic IPO, the Hong Kong Stock Exchange, which is continuously gaining momentum, is poised to become a focal point of capital market attention.
Feb 02, 2024 03:22 PM
Briefing Feb 08, 2022 09:49 AM
The infrastructure sector continued to strengthen
Technology
Sunpure Technology Secures CNY 100M in Series A for Photovoltaic Power Plant Innovation
The demand for intelligent solutions in the photovoltaic power plant industry is growing rapidly, leading to accelerated technological iteration in photovoltaic intelligent robot products.
Jan 31, 2024 10:37 AM
Briefing Jan 23, 2022 05:59 PM
· Healthcare
Kangtai biology: CDE starts the on-site verification of the registration of freeze-dried human rabies vaccine (human diploid cells)
See more
Read next
Insight
In-depth
Insight
In-depth